homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

September 21, 2021

Sonoma Biotherapeutics

Sonoma Biotherapeutics, an immune tolerance company focused on the development of regulatory T cell therapies, appointed Doug Sheehy as chief legal officer and secretary. Sheehy is a senior biotechnology executive who has managed global legal and compliance operations for multiple companies. Prior to joining Sonoma, he served as general counsel and secretary for Aimmune Therapeutics. Sheehy previously served as executive vice president, chief administrative officer, general counsel and secretary of Codexis, and prior to that he served as executive director, legal at CV Therapeutics. Sonoma Biotherapeutics is based in South San Francisco and Seattle.




Email or user name:
Password:
 
Forgot password? Click here.